MRE-269
CAS No. 475085-57-5
MRE-269 ( MRE-269; MRE269; MRE 269; ACT-333679 )
产品货号. M17517 CAS No. 475085-57-5
Ursonic acid belongs to the family of Ursane Triterpenes whose structure is based on the pentacyclic ursane skeleton. It has potential as HIV-1 Protease Inhibitor.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥381 | 有现货 |
|
10MG | ¥721 | 有现货 |
|
25MG | ¥1158 | 有现货 |
|
50MG | ¥1588 | 有现货 |
|
100MG | ¥2673 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称MRE-269
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ursonic acid belongs to the family of Ursane Triterpenes whose structure is based on the pentacyclic ursane skeleton. It has potential as HIV-1 Protease Inhibitor.
-
产品描述MRE-269, also known as ACT-333679, is a long-acting and highly selective prostacyclin receptor agonist. MRE-269, the active form or metabolite of Selexipag (NS-304), is much more selective for the IP receptor than are the prostacyclin analogs beraprost and iloprost, which also have high affinity for the EP(3) receptor.
-
同义词MRE-269; MRE269; MRE 269; ACT-333679
-
通路Others
-
靶点Other Targets
-
受体HIV-1 protease
-
研究领域Cardiovascular Disease
-
适应症——
化学信息
-
CAS Number475085-57-5
-
分子量419.52
-
分子式C25H29N3O3
-
纯度98%
-
溶解度DMSO : ≥ 50 mg/mL. 119.18 mM; H2O : < 0.1 mg/mL
-
SMILESCC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1C)C)C(=O)O
-
化学全称2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
PTD-p65-P1 Peptide T...
Ptd-p65-p1 Peptide TFA is a nuclear transcription factor nf-kappab inhibitor, consisting of a membrane transport Peptide sequence derived from antennapedia linked to p65-p1, selectively inhibiting nf-kappab activity induced by various stimuli.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Notoginsenoside L13
Reference standards.